These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24394117)

  • 1. [A case of facial nerve palsy induced by nab-paclitaxel].
    Minatani N; Kosaka Y; Sengoku N; Kikuchi M; Nishimiya H; Waraya M; Enomoto T; Tanino H; Watanabe M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2375-7. PubMed ID: 24394117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52).
    von Minckwitz G; Conrad B; Reimer T; Decker T; Eidtmann H; Eiermann W; Hackmann J; Möbus V; Marmé F; Potenberg J; Stickeler E; Simon E; Thomssen C; Huober J; Denkert C; Alfer J; Jackisch C; Nekljudova V; Burchardi N; Loibl S;
    Cancer; 2015 Oct; 121(20):3639-48. PubMed ID: 26111104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy for breast cancer with weekly nab-paclitaxel followed by epirubicin and cyclophosphamide--results of a case series.
    Hahn A; Schlotter CM; Rossmanith WG; Ulmer HU; Staiger HJ; Villena C
    In Vivo; 2014; 28(2):235-41. PubMed ID: 24632979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case report of liver metastasis of breast cancer successfully treated by hepatic arterial infusion of docetaxel and systemic administration of nab-paclitaxel].
    Satoh E; Ebuchi M; Maruyama M; Akazawa N; Suzuki K; Uehira D; Ono S; Yonekura K; Murakata A; Tanami H; Maruyama S; Sugano N; Sakoma T
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2066-7. PubMed ID: 23267978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral facial nerve palsy secondary to the administration of high-dose paclitaxel.
    Lee RT; Oster MW; Balmaceda C; Hesdorffer CS; Vahdat LT; Papadopoulos KP
    Ann Oncol; 1999 Oct; 10(10):1245-7. PubMed ID: 10586344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of nab-paclitaxel 125 mg/m
    Furlanetto J; Jackisch C; Untch M; Schneeweiss A; Schmatloch S; Aktas B; Denkert C; Wiebringhaus H; Kümmel S; Warm M; Paepke S; Just M; Hanusch C; Hackmann J; Blohmer JU; Clemens M; Costa SD; Gerber B; Nekljudova V; Loibl S; von Minckwitz G
    Breast Cancer Res Treat; 2017 Jun; 163(3):495-506. PubMed ID: 28315068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Case of a Corneal Disorder after Breast Cancer Treatment with Nab-paclitaxel].
    Hosotani Y; Morimatsu T; Takata M; Mimura O
    Nippon Ganka Gakkai Zasshi; 2016 Jun; 120(6):449-53. PubMed ID: 27487717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complete response of advanced breast cancer with lymph node metastases to nab-paclitaxel therapy-report of a case].
    Hara Y; Sakurai K; Enomoto K; Matsumoto K; Ueda Y; Hagiwara M; Waga E; Nagashima S; Tani M; Amano S
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2080-2. PubMed ID: 23267983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bi-weekly nab-paclitaxel and trastuzumab therapy effective against recurrent breast cancer with multiple lung metastases in elderly patient who had previously undergone two chemotherapeutic regimens for treatment of metastatic disease-a case Report].
    Sakurai T; Jinta E; Suzuma T; Yoshimura G; Umemura T; Sakurai T
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1703-6. PubMed ID: 23152023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
    Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Two cases of stage IV breast cancer with severe hypercalcemia].
    Ohsako T; Yamamoto Y; Kawazoe T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O; Sakamoto N; Iwase H
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):223-6. PubMed ID: 16484860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High pathologic complete response in Her2-positive, early-stage breast cancer to a novel nonanthracycline neoadjuvant chemotherapy.
    Zelnak AB; Nikolinakos P; Srinivasiah J; Jonas W; Pippas A; Liu Y; Li X; Torres M; O'Regan RM;
    Clin Breast Cancer; 2015 Feb; 15(1):31-6. PubMed ID: 25065563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer: a multicenter phase II trial.
    Futamura M; Nagao Y; Ishihara K; Takeuchi M; Nakada T; Kawaguchi Y; Asano M; Kumazawa I; Shiroko T; Morimitsu K; Mori R; Nawa M; Shimokawa T; Yoshida K
    Breast Cancer; 2017 Jul; 24(4):615-623. PubMed ID: 28050738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study.
    Robert N; Krekow L; Stokoe C; Clawson A; Iglesias J; O'Shaughnessy J
    Breast Cancer Res Treat; 2011 Jan; 125(1):115-20. PubMed ID: 20945091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Case of HER2-Positive Breast Cancer Treated with Nipple-Sparing Mastectomywith Immediate Reconstruction Using a Tissue Expander after Nab-Paclitaxel Combined with Chemotherapy].
    Nonomura A; Aomatsu N; Tei S; Haraoka G; Tsujio G; Yamakoshi Y; Wang E; Nagashima D; Hirakawa T; Iwauchi T; Nishii T; Morimoto J; Nakazawa K; Uchima Y; Takeuchi K
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2056-2058. PubMed ID: 28133220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer.
    Yardley D; Burris H; Peacock N; Raefsky E; Melnik M; Inhorn R; Shipley D; Hainsworth J
    Breast Cancer Res Treat; 2010 Sep; 123(2):471-5. PubMed ID: 20658263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term response to eribulin in patients with metastatic breast cancer-report of 2 cases].
    Hara Y; Sakurai K; Nagashima S; Suzuki S; Waga E; Matsumoto K; Hagiwara M; Maeda T; Hirano T; Enomoto K; Tani M; Amano S
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2372-4. PubMed ID: 24394116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Axillary Arterial Bleeding with Administration of Bevacizumab plus Paclitaxel in a Patient with Recurrent Breast Cancer-A Case Report].
    Tsuruda Y; Masuda T; Hayashi N; Noda M; Otsu H; Kuroda Y; Eguchi H; Tanaka F; Natsugoe S; Mimori K
    Gan To Kagaku Ryoho; 2020 Jan; 47(1):117-119. PubMed ID: 32381877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locally advanced breast cancer with bleeding - two cases effectively treated with bevacizumab plus weekly paclitaxel.
    Ishizuna K; Ninomiya J; Ogawa T; Kojima M; Kawashima M; Nozaki M; Yamagishi H; Ueda Y
    Gan To Kagaku Ryoho; 2014 May; 41(5):637-40. PubMed ID: 24917012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer.
    Bando H; Shimodaira H; Fujitani K; Takashima A; Yamaguchi K; Nakayama N; Takahashi T; Oki E; Azuma M; Nishina T; Hironaka S; Komatsu Y; Shitara K
    Eur J Cancer; 2018 Mar; 91():86-91. PubMed ID: 29353164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.